chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received Moderna COVID vaccine on 1/22/21 (lot # 028L20A), 2/25/21 (lot # 002A21A), 11/3/21 (lot # 026D21A), and 4/3/22 (lot # 002M21A). Patient tested positive for COVID (external result) on 7/1/22. On 7/4/22, patient admitted to our inpatient facility (med/surgical unit) with acute hypoxemic respiratory failure due to COVID-19 pneumonia and hypokalemia. Patient discharged home on 7/6/22.
Nov 3rd 2008 rec'd flu shot pt sore for 1st couple of days. Ok until Nov. 15 pain (L) shoulder just below acromion #3. Nov 20 call Dr. & used Alleve, Tylenol. Nov 19 pain increased #8 no sleeping. Nov-22 went to ER walkin clinic. Nov 22 pain. #10. Couldn't lift her own arm- someone had to lift arm. Took Alleve, Tylenol and took 1/2 tab of codeine. Now decreased #4. Will follow up with Dr to get physical therapy. No abscess found faxed x-ray.
Left under arm (lymph node) very sore; This is a spontaneous report from a contactable consumer, the patient. A 43-years-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 26Apr2021 at 12:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included fluvoxamine maleate (LUVOX), lamotrigine (MANUFACTURER UNKNOWN), simvastatin (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN) and proto from an unknown date for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 05Apr2021 at 12:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 28Apr2021, the patient experienced left underarm (lymph node) very sore. The clinical outcome of the event left underarm (lymph node) very sore was not recovered at the time of the report.  No follow-up attempts are needed; information about the lot number cannot be obtained.
Chills, fever, extreme fatigue, headache, muscle ache. I stayed in bed from 6pm 4/17 until 8am 4/19/2021.  The fever lifted at 10pm on 4/18/2021.
Severe (extreme) pain in right shoulder, right side of neck, right shoulder blade, and from injection site all the way down to right wrist. Very limited mobility of right arm, loss of sleep due to pain.
Fever and fine red papular rash on trunk 1/12 - 1/13/03 with rash persisting to 1/21/03 on back. Treatment: Fever, observation and reassurance.
Information has been received from a medical assistant referring to a 15 months old female patient. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 15-JUN-2015, the patient was vaccinated with an improperly stored dose of M-M-R II (lot # K021151 with expiration date 02-NOV-2016; dose and route of administration were not reported). No adverse effects were reported. This is one of several cases received from the same source. Additional information has been requested.
Patient was given expired vaccine. Vaccine expiration date 09/30/2022. Vaccine administered on 10/06/2022. No adverse effects reported so far
Patient administered Menactra and Yellow Fever vaccinations due to travel abroad.  Completed vaccinations at approximately 4:35pm. Upon completing paper work and providing records to parents at approx. 5:45pm, parents noted child complained of coughing, chest hurting, early back-side itching. Benadryl IM given, 911 called, EMS assessment and transport to hospital.
Information has been received from a lawyer regarding a case in litigation concerning a patient (age and gender unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. On or about 19-JUN-2013, the patient was vaccinated with ZOSTAVAX, (lot# and route unknown) as recommended for routine adult health maintenance for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain condition of herpes zoster or shingles. On or about 10-SEP-2016, the patient was treated at a medical facility for a blistering vesicular outbreak, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX, for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Immediate soreness to site.  Increasingly got worse... pain at upper arm/shoulder area.  Difficulty lifting arm, rotating and sleeping.  Went to Chiropractor who tried manipulating it, to no avail.  Sent for MRI and images came back with incredible inflammation at injection site-- causing swelling to joints & tendons.
@ 2:00 am 2/14/2021 woke up with temp 100.4, shaking, chills, shivering, aches & pains throughout body rash on right arm where shot given & swollen, Nausea, Vomiting, cough w Phelgm, took  2 Tylenol (1000 mg) & 4 mg of Zofran for nausea / vomiting. Fever broke @ 8-9 am 2/14/2021but rest of symptoms kept on till 2/17/2021. Rash on arm where shot given was still there & pain at injection site. Also, heart racing at times throughout all of this and chest hurting. Blood sugars were not good during this time period either.   Found out 5/19/2021 from arteriogram done that heart is now only pumping at 35% & I have Non Sustained Ventricular Tachycardia w Congestive Heart failure. Also had place on right inner heel that was swollen when I got up on 3/9/2021. Thought it was cellulitis, but negative on that. Was sent to foot dr & biopsy done, thinks it?s due to vascular/ neuropathy
Did have a headache and no appetite the morning of 12/01/2009.  He did go to school and received a nasal H1N1 in the early morning. He did take Tylenol sometime during the morning, but his headache was worse by noon.  His temp by mid afternoon was 101 degrees. No complaints of headache.  He was given more Tylenol and went to sleep.  His temp between 8 pm and 9 pm was taken again and was 104.4 degrees.  He was given ibuprofen which did not bring his temp down.  He was given another dose of Tylenol and went to sleep.  His temp the morning of 12/02/2009 was normal.
pt recv vax 28NOV97 & 6DEC97 pt exp nasal congestion & rectal temp 103+;fever persisted to 103 for 5 days;pt later exp a dry cough;9DEC97 pt devel small red dots neck & upper torso;dx measles rash;
Chills, fever, anorexia, fatigue for 24 hours. Following day - non pruritic rash at injection site. Tylenol and Advil
Right thigh swollen, erythematous, and tender this am when child awoke. Shortly after, the left thigh looked the same with swelling and redness. Mother applied hot pack. At 1400 today, the left thigh appeared normal, the right is still swollen with overlying erythema, measuring 1/2 in larger in circumference than the left.
Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Upon in internal review on 21 May 2021, the age was corrected to unknown age.  Based on the current available information and temporal association between the use of the product and onset of the event a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jan-2021: Upon internal review on 27 May 2021, it was discovered that the patient age was incorrectly captured as 121 years and DOB mentioned in source document was 01-Jan-1900, which was a MI error. The patient age and narrative has been updated to unknown age with reports re-submission and significant amendment is performed for the correction.; Sender's Comments: Based on the current available information and temporal association between the use of the product and onset of the event a causal relationship cannot be excluded.
Patient had wheal and erythema - no notation of date or time of onset. At today's visit - 6 days from vaccination - pt still had 3 cm wheal and 5 cm ery - no acute distress.
COVID 19; COVID 19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 26-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "Depression" (unspecified if ongoing); "PTSD" (unspecified if ongoing); "Anxiety" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Amoxicillin, reaction(s): "Allergy:Amoxicillin". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19". Therapeutic measures were taken as a result of drug ineffective, covid-19. The patient received Paxlovid from 07Jun2022 to 12Jun2022 for the treatment of COVID-19.   Follow-up attempts are completed. No further information is expected.
Injections given 8/12/02, pt had night sweats, chills that evening, redness at sites. 8/13/02 pt worsened with temp 100 degrees. Inj site red, hot. Pt hospitalized with dx of cellulitis vs drug rxn. 10/21/02 Per review of hospital d/c summary add: confirmation of acute cellulitis and acute reaction to pneumococcal vaccine treated with IV cefazolin. Additional symptoms upon admission were generalized aches and pains, fatigue, headache, and tachycardia. Allergic rhinitis symptoms present during hospitalization were treated with Claritin-D and Flonase nasal spray.
rash around injection site; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE RASH (rash around injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jan-2021, the patient experienced VACCINATION SITE RASH (rash around injection site). At the time of the report, VACCINATION SITE RASH (rash around injection site) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
was advised to stay in store for 10-15 minutes.  he responded with he had read online that he could wait in his car.  he left, got to the car, sat & fainted
Starting the evening and the following morning after receiving the vaccine, my hands and feet were very swollen, bright red and hot. I contacted my PCP and they told me to take an antihistamine (likely due to an allergic reaction). I had eczema as a child so they thought it was related to that. The Benadryl did help it resolve on its own. It still occasionally occurs randomly. After the booster, I had the similar symptoms with a "smoky" smell in my nose and mild tingling in my fingertips. The smoky smell does reoccur randomly along with the redness in the hands.
Patient had a syncope episode after her Janssen vaccine.  She was monitored for 15 minutes and her husband came to pick her up.
This spontaneous report was received from a certified medical assistant, referring to an unspecified number of patients of unknown age and gender. Information regarding concurrent conditions and medical history was not provided. On an unspecified date unspecified number of M-M-R II vaccines were exposed to 58 F for 94 hours. After that, on unspecified dates, the patients were vaccinated with lot numbers: L019989 (expiration date: 01-JUN-2017), and K021151 (expiration date 02-NOV-2016). No adverse events were reported. The medical assistant stated that the vaccines were not previous exposed to temperature excursion. Information was recorded from a data logger. This is one of two reports received from the same source. Additional information has been requested.
Day 6- 3 months old left wrist tattoo is all of the sudden raised/itchy like it?s brand new. It?s been flat and healed for months
administered past the 30 day refrigeration time; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered past the 30 day refrigeration time) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered past the 30 day refrigeration time). On 27-Aug-2021, EXPIRED PRODUCT ADMINISTERED (administered past the 30 day refrigeration time) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.  Per reporter,the Moderna COVID Vaccine was refrigerated on 20-APR-2021, and administered to the patient on 27-AUG-2021.  No treatment information was provided.
This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore Arm) and CHILLS (Chills) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014F21A, 011A21A and 030L20A) for COVID-19 vaccination. Concurrent medical conditions included Sulfonamide allergy (Sulfur allergy), Allergy to antibiotic (Erythromycin allergy), Hypothyroidism and Anxiety. Concomitant products included SERTRALINE for Anxiety, LEVOTHYROXINE SODIUM (SYNTHROID) for Hypothyroidism. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore Arm) and CHILLS (Chills). At the time of the report, PAIN IN EXTREMITY (Sore Arm) and CHILLS (Chills) outcome was unknown. On 26-Sep-2021, the patient received a first booster dose (Lot: 014F21A) of Moderna vaccine. Patient had never tested positive for COVID-19 and she did not received any other vaccine within 1 month prior to Moderna Covid-19 vaccine. Patient did not seek for medical care attention and she did not experienced a similar event on the past. No treatment  medications were reported. This case was linked to MOD-2022-541551, MOD-2022-541804, MOD-2022-541807 (Patient Link).
On August 4, received Hep A, polio and Tdap vaccines. During the first week of Sept 2010, patient noticed the first lesion on his right forearm. Since then, his lesions have spread. On October 15 he had the flu shot and then on October 19 received MMR. On November 5, he saw derm and had KENALOG Injections into some of his more problematic lesions. On November 15 he had an HBV vaccine. Within the next 4-6 weeks, he noted further exacerbations, specifically on his forearms. Notes from clinical visit on 20 OCT 2010: ...noticed 'rashes' on his extremities and low back areas. Starts as a small papule and gets larger... Lesions are occ pruritic. Not painful. Saw a civilian dermatologist sev wks ago and told it was 'lichen...'. And given a steroid cream and Ivermectin (took 6 tabs twice a week apart) - last dose 2 days ago. Physical exam: Skin: several slightly raised hyperpigmented (some almost purple in color) 3 mm to 5 mm in size over his arms, anterior tibias, lower lumbar area, under right axilla and right neck area. Notes from Derm Eval on 5 Nov 2010: 2 months of pruritic lesions on the forearms, shins, dorsal feet and lumbar back. Previous diagnosis of LP, treating with Betamethasone. Physical exam: Lesions on the upper extremities. Lesions on the back. Lesions on the lower extremities. Normal except as noted multiple 3-6 mm purple polygonal flat topped papules and small plaques on the flexural forearms, wrists, shins, dorsal feet and ankles and lumbar back. Plaques on shins and lower back on lichenified and scaly. Assessment/Plan: Lichen Planus: Lesions classic for lichen planus. Continuing treating with Betamethasone daily during the week. Recommend taking weekends off. Explained risks of chronic steroid use to include striae and atrophy. Several particularly bothersome plaques injected today w/ILK.
This spontaneous report has been received from a pharmacist refers to a 76 years old female patient. The patient was vaccinated with a dose of 23-JUL-2012. No other co-suspects were reported. No concomitant medications were reported. On 25-JUL-2012 the patient developed a local injection site reaction after vaccination with ZOSTAVAX. There was a "round angry are" around the injection site. The patient sought medical attention by contacting the pharmacist. BENADRYL and hydrocortisone cream were given to patient for AE treatment. The patient was recovered on 28-JUL-2012. Additional information is not expected.
Pt vaccinated with Engerix-B 1JUL90, developed edema, itching, rash, swelling (11JUL90). Was put on Atarax & Prednisone. 16JUL90 rash persisted. Reporter indicated events were considered life-threatening.
Child recieved sq injection of mmr and varicella and immediately developed hive like local rash. Provider noted that the very next day a child also developed a very similar swelling and hive like rash after getting dtap and varicella so suspect varicella.
Started with itchiness, then progressed to hives, swelling of face, hands and feet.  Passed out several times.  Went to emergency room for antihistimines to combat swelling and hives and IV for fluids for dehydration.  Hives and swelling lasted about a week, still (a month later) combatting redness on body whenever touch skin and itchiness.
Patient is not in the recommended age range for the vaccine. The recommended age is 16 years and older and this patient is 15 years old. Patient has had no adverse reaction to the vaccine at this time.
pt has had pain in his left arm off and on since the vaccine was given.  there is a lump under the skin where the vaccine was given. patient says lump comes and goes and changes in size.  the lump causes a throbbing pain and last night was the size of an egg.  his arm sometimes hurts when he lifts it.
Sharp pain in lower abdomen. Two days later started period 2 weeks early. Lasted longer than normal.
Arm became red and swollen evening of injection. Patient reports arm sore and itchy; left upper arm with 8 cm ring of erythema and swelling, mild tenderness. Treated with cetirizine and mometasone cream.
Itchy, red area around injection site bout the size of a fist. Red and itchy. Patient has been taking Benadryl and using cortisone cream. Area is better per patient
Chills, joint pain, and headache starting 4 hours after the covid vaccine. S/S have yet to subside.
Over a week later after having the first dose of Moderna vaccine I have developed a hard knot at the injection site. It is slightly raised, swollen, red, warm to the touch, and itchy.
26APR91 pt recvd Engerix-B & devel weakness & vomiting which lasted 24 hrs p/inject;
This spontaneous report as received from a nurse practitioner regarding a patient of unknown age and gender. The patient's concurrent condition, medical history and concomitant medications were not reported. On 15-DEC-2015, patient received improperly stored VARIVAX dose 2, from batch/lot #L015045 (expiry date, dose units, route and anatomical location were not specified). Concomitant medication were not reported.  No adverse effects were reported. The reporter stated that inconsistencies in storage temperature were identified on extensive review and records. The reporter stated that vaccine was not thawed. The nurse practitioner reported that there was insufficient data to provide 100 percent assurance on vaccine stability. This is one of several reports received from the same reporter. Additional information has been requested.
Cold symptoms; Within hours injection site became red; injection site became red, itchy; n hours injection site became hot; hours injection site became red, itchy, hot and raised; Patient experienced injection site pain; connective tissue from elbow to wrist painful; fatigue; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 12-Apr-2021 and was forwarded to Moderna on 12-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Within hours injection site became red), VACCINATION SITE PRURITUS (injection site became red, itchy), VACCINATION SITE WARMTH (n hours injection site became hot), VACCINATION SITE SWELLING (hours injection site became red, itchy, hot and raised) and VACCINATION SITE PAIN (Patient experienced injection site pain) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Latex allergy. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) and TOFACITINIB CITRATE (XELJANZ) for an unknown indication.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (Within hours injection site became red), VACCINATION SITE PRURITUS (injection site became red, itchy), VACCINATION SITE WARMTH (n hours injection site became hot), VACCINATION SITE SWELLING (hours injection site became red, itchy, hot and raised), VACCINATION SITE PAIN (Patient experienced injection site pain), PAIN IN EXTREMITY (connective tissue from elbow to wrist painful) and FATIGUE (fatigue). On 10-Apr-2021, the patient experienced NASOPHARYNGITIS (Cold symptoms). On 04-Apr-2021, VACCINATION SITE PAIN (Patient experienced injection site pain) outcome was unknown, PAIN IN EXTREMITY (connective tissue from elbow to wrist painful) and FATIGUE (fatigue) had resolved. On 10-Apr-2021, NASOPHARYNGITIS (Cold symptoms) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (Within hours injection site became red), VACCINATION SITE PRURITUS (injection site became red, itchy), VACCINATION SITE WARMTH (n hours injection site became hot) and VACCINATION SITE SWELLING (hours injection site became red, itchy, hot and raised) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient took Benadryl as treatment
Large local reaction, pain and swelling - 7cm x 10cm on left anterior thigh.